MCDANIEL RAYMOND W - 20 Feb 2025 Form 4 Insider Report for RAYMOND JAMES FINANCIAL INC (RJF)

Reporting relationship: Director
Issuer ticker: RJF
Reported as of: 20 Feb 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 24 Feb 2025, 11:56:45 UTC
Prior SEC filing: 13 Jan 2025
Next SEC filing: 28 Apr 2025
Source filing: View source filing
Reporting owner signature: /s/ Raymond W. McDaniel by Jonathan J. Doyle as Attorney-in-Fact

Key filing fact

MCDANIEL RAYMOND W filed Form 4 for RAYMOND JAMES FINANCIAL INC (RJF) on 24 Feb 2025.

Key facts

This page summarizes MCDANIEL RAYMOND W's Form 4 filing for RAYMOND JAMES FINANCIAL INC (RJF).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 24 Feb 2025, 11:56.

Change

Previous filing in this sequence was filed on 13 Jan 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RJF transaction

Common Stock

Options Exercise

Transaction value: $0
Shares: +1,711
Change %: +93%
Price: $0.000000
Shares after: 3,557
Date: 20 Feb 2025
Ownership: Direct
Footnotes: F1

RJF transaction

Common Stock

Award

Transaction value: $0
Shares: +1,253
Change %: +35%
Price: $0.000000
Shares after: 4,810
Date: 20 Feb 2025
Ownership: Direct
Footnotes: F2, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

RJF transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value: $0
Shares: -1,711
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 20 Feb 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,711
Exercise price
Footnotes: F1, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Each Restricted Stock Unit (RSU) represents a contingent right to receive, upon vesting of the award: (i) one share of common stock, and (ii) accrued cash in lieu of dividends.

Footnote F2

Consists of a grant of Deferred Restricted Stock Units ("DRSUs") as part of compensation for service on the registrant's Board of Directors. Upon vesting, the DRSUs convert to the right to receive shares of common stock on a one-to-one basis, together with accrued cash in lieu of dividends. The DRSUs vest at the date of the next succeeding annual shareholders meeting following the grant date, but no later than March 15 of the calendar year following grant. Pursuant to an irrevocable election by the reporting person, settlement of the DRSUs will be deferred following vesting until the date the reporting person terminates his or her service on the Board of Directors.

Footnote F3

Includes DRSUs.

Footnote F4

The award vested in accordance with its terms, which provided for vesting at the date of the next succeeding annual shareholders meeting following the grant date, but no later than March 15 of the calendar year following grant.

SEC remarks

This Form 4 reports (i) the acquisition by the reporting person of DRSUs resulting from an annual grant to the registrant's non-executive directors and (ii) the vesting of RSUs awarded to the reporting person.